Found: 14
Select item for more details and to access through your institution.
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 863, doi. 10.1007/s10549-020-06053-y
- By:
- Publication type:
- Article
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 239, doi. 10.1007/s10549-019-05139-6
- By:
- Publication type:
- Article
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2021, v. 12, n. 6, p. 1456, doi. 10.1002/jcsm.12828
- By:
- Publication type:
- Article
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 46, p. 4878, doi. 10.1093/eurheartj/ehad085
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 642, doi. 10.1634/theoncologist.2016-0406
- By:
- Publication type:
- Article
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 139, doi. 10.1634/theoncologist.2016-0268
- By:
- Publication type:
- Article
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 418, doi. 10.1634/theoncologist.2015-0321
- By:
- Publication type:
- Article
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1105, doi. 10.1634/theoncologist.2015-0125
- By:
- Publication type:
- Article
Cardiotoxicity of Contemporary Breast Cancer Treatments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy.
- Published in:
- Cardio-Oncology, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40959-023-00163-4
- By:
- Publication type:
- Article
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 19, p. 1, doi. 10.1161/JAHA.123.029465
- By:
- Publication type:
- Article
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/9363951
- By:
- Publication type:
- Article
Cardiac ATTR amyloid nuclear imaging-not all bone scintigraphy radionuclide tracers are created equal.
- Published in:
- 2018
- By:
- Publication type:
- journal article